COVID-19 Nasal Swab Trial

Orthopaedic Innovation Centre

Status: Completed

Conditions: Covid19

Treatments: Device: CanSwab

Study type: Interventional

Funder types: Other

Identifiers

NCT04649424

B2020:121

Details and patient eligibility

About

The purpose of this trial is to compare 2 types of nasonasopharyngeal swabs (a new design to a conventional nylon-flocked nasopharyngeal swab) for effectiveness.

Full description

Compare the Precision ADM "CanSwab" nasopharyngeal swab to a conventional nylon-flocked nasopharyngeal swab on the basis of:

1. The amount of SARS-CoV2 virus (COVID-19) collected by swabs, measured in CT (thermal cycles)
2. Clinical concordance rate
3. Patient comfort during nasopharyngeal sampling procedure

Enrollment: 169 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18 years and older
• Ability to provide informed consent
• COVID-19 positive cohort only: a previous, positive COVID-19 test in the last 5 days and patient remains symptomatic

Exclusion criteria

• Malformation of the base of the known skull
• Active nosebleed before the start of the sample

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

169 participants in 2 patient groups

CanSwab - 1st

Experimental group

Description:

CanSwab will be swabbed first

Treatment:

Device: CanSwab

CanSwab - 2nd

Experimental group

Description:

CanSwab will be swabbed second.

Treatment:

Device: CanSwab